Citius Oncology, Inc. (CTOR) ROE
- 2026-06-30: ROE -114.06%.
- 2026-03-31: ROE -120.53%.
- 2025-12-31: ROE -40.46%.
- 2025-09-30: ROE -55.19%.
Complete source-backed roe history.
- Available history
- 2022-12-31 to 2026-06-30
- Data captured
Historical ROE
| Date | ROE |
|---|---|
| 2026-06-30 | -114.06% |
| 2026-03-31 | -120.53% |
| 2025-12-31 | -40.46% |
| 2025-09-30 | -55.19% |
| 2025-06-30 | -82.04% |
| 2025-03-31 | -72.89% |
| 2024-12-31 | -55.90% |
| 2024-09-30 | -45.84% |
| 2024-06-30 | -83.25% |
| 2024-03-31 | -44.28% |
| 2023-12-31 | -14.70% |
| 2023-09-30 | 5.42% |
Annual ROE
| Date | ROE |
|---|---|
| 2025-09-30 | -55.19% |
| 2024-09-30 | -45.84% |
| 2023-12-31 | -121.72% |
| 2023-09-30 | -49.72% |
| 2022-12-31 | 110.22% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Anixa Biosciences Inc (ANIX) | United States | $0.096B | |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |